Wallace Audrey, Morris Christopher G, Kirwan Jessica, Amdur Robert J, Werning John W, Mendenhall William M
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.
Am J Clin Oncol. 2007 Dec;30(6):612-6. doi: 10.1097/COC.0b013e31815aff1f.
To evaluate the efficacy of radiotherapy (RT) alone or combined with surgery for the treatment of the nasal vestibule squamous cell carcinomas.
Seventy-one patients with squamous cell carcinoma of the nasal vestibule were treated with definitive RT at the University of Florida, and 8 patients with advanced T4 cancers were treated with combined surgery and RT. Patients were followed from 4 months to 27.7 years (mean 9.0 years, median 7.9 years). Follow-up on living patients ranged from 6 months to 27.7 years (mean 10.0 years, median 8.1 years).
The 5-year outcomes were: local control, 87%; local-regional control, 77%; freedom from distant metastases, 94%; cause-specific survival, 90%; and survival, 76%. The 5-year local control rates for patients treated with definitive RT were: T1-T2, 95%; T4, 71%; and overall, 86% (P = 0.0046). Local control was achieved in 8 of 8 patients treated with surgery and RT.
RT results in a high cure rate for T1-T2 and favorable T4 tumors. Surgery and RT result in an improved likelihood of cure for patients with extensive T4.
评估单纯放疗(RT)或联合手术治疗鼻前庭鳞状细胞癌的疗效。
佛罗里达大学对71例鼻前庭鳞状细胞癌患者进行了根治性放疗,8例晚期T4期癌症患者接受了手术联合放疗。对患者进行了4个月至27.7年的随访(平均9.0年,中位数7.9年)。对在世患者的随访时间为6个月至27.7年(平均10.0年,中位数8.1年)。
5年的结果如下:局部控制率为87%;局部区域控制率为77%;无远处转移率为94%;病因特异性生存率为90%;总生存率为76%。接受根治性放疗患者的5年局部控制率为:T1-T2期,95%;T4期,71%;总体为86%(P = 0.0046)。8例接受手术联合放疗的患者中有8例实现了局部控制。
放疗对T1-T2期及预后良好的T4期肿瘤治愈率较高。手术联合放疗可提高广泛T4期患者的治愈可能性。